Accueil / Tag Archives: California

Tag Archives: California

ROTH Capital Partners Announces the Addition of Eric B. Cheng, Managing Director, Head of Healthcare Investment Banking

Thursday, April 27th 2017 at 1:00pm UTC NEWPORT BEACH, Calif.–(BUSINESS WIRE)– ROTH Capital Partners (ROTH), www.roth.com, a full service investment bank focused on serving emerging growth companies and their investors, today announced that Eric B. Cheng has joined the firm as Managing Director, Head of Healthcare Investment Banking. Mr. Cheng …

Plus »

joimax® Announces 510(k) Clearance for Its Endovapor® 2 Multi Radio Frequency System During Its First Presentation at the Annual Scientific Meeting of the American Association of Neurological Surgeons (AANS) 2017, in Los Angeles

Wednesday, April 26th 2017 at 7:25pm UTC IRVINE, Calif.–(BUSINESS WIRE)– joimax®, the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Endovapor® 2 Multi Radio Frequency …

Plus »

Acutus Medical® Announces Completion of Enrollment for UNCOVER AF™ Study of AcQMap® in Persistent Atrial Fibrillation

Thursday, April 27th 2017 at 12:00pm UTC CARLSBAD, Calif.–(BUSINESS WIRE)– Acutus Medical®, a company committed to transforming the lives of millions of patients with complex arrhythmias, today announced that enrollment has been completed in its pivotal Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Rhythms in Atrial …

Plus »

PURE Bioscience Receives USDA Permission Letter and FDA FCN Acknowledgement Letter

Thursday, April 27th 2017 at 12:36pm UTC SAN DIEGO–(BUSINESS WIRE)– PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced that the Company has received two required key regulatory notifications on the Company’s path to commercialize PURE Control® as a superior raw poultry processing …

Plus »

Axial Biotherapeutics Expands Board of Directors with Appointments of Independent Members Ronald C. Renaud Jr. and Henry C. (“Hank”) Wolf

Wednesday, April 26th 2017 at 12:00pm UTC BOSTON & PASADENA, Calif.–(BUSINESS WIRE)– Axial Biotherapeutics, a biotechnology company building a unique class of microbial-targeted CNS therapeutics, today announced the expansion of its Board of Directors with the appointment of two independent members, Ronald C. Renaud Jr., Chief Executive Officer of RaNA …

Plus »

Revance Therapeutics to Release First Quarter 2017 Financial Results Tuesday, May 9, 2017

Tuesday, April 25th 2017 at 8:05pm UTC – Conference Call Scheduled for Tuesday, May 9, 2017 at 4:30pm ET – NEWARK, Calif.–(BUSINESS WIRE)– Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing botulinum toxin products for use in aesthetic and therapeutic indications, today announced that the company will release first quarter …

Plus »

SYNLAB and Counsyl Enter Into Agreement to Offer Genetic Screening for Serious Inherited Health Conditions in Europe and Latin America

Wednesday, April 26th 2017 at 3:00pm UTC Counsyl’s Expanded Carrier Screening Test Helps to Identify Couples At-Risk of Having a Child With a Genetic Condition MUNICH & SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– SYNLAB, the leading laboratory diagnostic services provider in Europe, and Counsyl, a DNA testing and genetic counseling service …

Plus »

BioTime, Inc. to Announce First Quarter 2017 Results on May 10, 2017

Wednesday, April 26th 2017 at 11:00am UTC Conference Call and Webcast on Wednesday, May 10, 2017, at 4:30 p.m. ET / 1:30 p.m. PT ALAMEDA, Calif.–(BUSINESS WIRE)– BioTime, Inc. (NYSE MKT:BTX), a clinical-stage biotechnology company developing and commercializing products addressing degenerative diseases, today announced that it will release first quarter …

Plus »

Simulations Plus Announces Quarterly Cash Dividend of $0.05 per Share

Wednesday, April 26th 2017 at 12:30pm UTC LANCASTER, Calif.–(BUSINESS WIRE)– Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and chemicals industries, today announced that its board of directors has declared its next ongoing quarterly cash dividend of $0.05 …

Plus »
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE !
Vous appréciez cet article ? Faites-nous part de vos commentaires.
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cuZWVpLWJpb3RlY2hmaW5hbmNlcy5jb20vd3AtY29udGVudC91cGxvYWRzLzIwMTUvMDcvU2F0cmEtMi5tcDQiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...